Pharmarise Holdings Corporation (TYO:2796)
Japan · Delayed Price · Currency is JPY 489.00
-2.00 (-0.41%)
Jul 31, 2026, 3:30 PM JST
Pharmarise Holdings Ratios and Metrics
Market cap in millions JPY. Fiscal year is June - May.
Millions JPY. Fiscal year is Jun - May.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
| 5,625 | 5,820 | 5,510 | 7,252 | 5,759 | 6,809 | |
Market Cap Growth | -0.78% | 5.63% | -24.02% | 25.92% | -15.42% | -5.58% |
Enterprise Value | 14,782 | 18,267 | 17,564 | 12,732 | 10,202 | 12,910 |
Last Close Price | 489.00 | 506.00 | 472.28 | 610.25 | 560.02 | 652.59 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
PE Ratio | 50.83 | 51.06 | - | - | 17.29 | 15.23 |
Forward PE | - | 7.30 | 7.30 | 7.30 | 7.30 | 7.30 |
PS Ratio | 0.08 | 0.08 | 0.09 | 0.13 | 0.11 | 0.13 |
PB Ratio | 0.82 | 0.85 | 0.80 | 0.98 | 0.82 | 1.02 |
P/TBV Ratio | - | - | - | 7.71 | 1.59 | 2.29 |
P/FCF Ratio | 2.18 | 2.25 | 8.18 | 3.24 | 2.69 | 20.39 |
P/OCF Ratio | 1.72 | 1.78 | 4.20 | 2.67 | 2.29 | 9.55 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
EV/Sales Ratio | 0.21 | 0.26 | 0.28 | 0.23 | 0.20 | 0.25 |
EV/EBITDA Ratio | 5.79 | 7.16 | 9.82 | 6.10 | 3.83 | 4.56 |
EV/EBIT Ratio | 15.61 | 19.29 | 59.54 | 13.90 | 7.09 | 8.49 |
EV/FCF Ratio | 5.72 | 7.08 | 26.06 | 5.68 | 4.77 | 38.65 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Debt / Equity Ratio | 2.21 | 2.21 | 2.07 | 1.71 | 1.31 | 1.48 |
Debt / EBITDA Ratio | 5.94 | 5.94 | 7.99 | 6.11 | 3.43 | 3.50 |
Debt / FCF Ratio | 5.87 | 5.87 | 21.19 | 5.69 | 4.27 | 29.68 |
Net Debt / Equity Ratio | 1.33 | 1.33 | 1.36 | 0.75 | 0.63 | 0.88 |
Net Debt / EBITDA Ratio | 3.58 | 3.58 | 5.24 | 2.68 | 1.65 | 2.09 |
Net Debt / FCF Ratio | 3.54 | 3.54 | 13.90 | 2.50 | 2.05 | 17.73 |
Asset Turnover | 2.15 | 2.15 | 2.07 | 2.06 | 2.21 | 2.13 |
Inventory Turnover | 17.26 | 17.26 | 16.06 | 18.65 | 19.12 | 17.79 |
Quick Ratio | 0.70 | 0.70 | 0.73 | 1.00 | 0.89 | 0.97 |
Current Ratio | 0.94 | 0.94 | 1.10 | 1.29 | 1.16 | 1.28 |
Return on Equity (ROE) | 1.57% | 1.57% | -5.29% | -4.74% | 5.07% | 7.02% |
Return on Assets (ROA) | 1.83% | 1.83% | 0.60% | 2.16% | 3.81% | 3.92% |
Return on Invested Capital (ROIC) | 0.83% | 0.91% | -76.46% | -17.94% | 3.97% | 4.20% |
Return on Capital Employed (ROCE) | 5.10% | 5.10% | 1.50% | 4.90% | 10.60% | 10.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Earnings Yield | 2.03% | 1.96% | -6.66% | -4.84% | 5.78% | 6.57% |
FCF Yield | 45.90% | 44.36% | 12.23% | 30.92% | 37.16% | 4.91% |
Dividend Yield | 2.86% | 2.77% | 2.96% | 2.29% | 2.50% | 2.15% |
Payout Ratio | 138.60% | 138.60% | - | - | 39.34% | 29.31% |
Buyback Yield / Dilution | -5.29% | -5.29% | -7.58% | 15.61% | -0.59% | -0.20% |
Total Shareholder Return | -2.42% | -2.52% | -4.61% | 17.90% | 1.91% | 1.95% |